AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 83 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $62,000 | -70.3% | 86,593 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $209,000 | -24.0% | 92,688 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $275,000 | -18.9% | 95,461 | +6.6% | 0.00% | 0.0% |
| Q2 2021 | $339,000 | +19.8% | 89,538 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $283,000 | +21.5% | 83,472 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $233,000 | +8.4% | 83,252 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $215,000 | -80.1% | 85,640 | +7.6% | 0.00% | -80.0% |
| Q2 2020 | $1,081,000 | +104.0% | 79,611 | +13.9% | 0.01% | +66.7% |
| Q1 2020 | $530,000 | +13.5% | 69,887 | -5.5% | 0.00% | +50.0% |
| Q4 2019 | $467,000 | +59.9% | 73,926 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $292,000 | -19.6% | 74,548 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $363,000 | -19.0% | 75,068 | +37.2% | 0.00% | -50.0% |
| Q1 2019 | $448,000 | +43.6% | 54,714 | -3.1% | 0.00% | +100.0% |
| Q4 2018 | $312,000 | +5.8% | 56,486 | +68.9% | 0.00% | 0.0% |
| Q3 2018 | $295,000 | -10.1% | 33,448 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $328,000 | +20.1% | 32,846 | +14.8% | 0.00% | 0.0% |
| Q1 2018 | $273,000 | -39.1% | 28,613 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $448,000 | -23.4% | 30,151 | +1.5% | 0.00% | -50.0% |
| Q3 2017 | $585,000 | +77.8% | 29,720 | +29.9% | 0.00% | +100.0% |
| Q2 2017 | $329,000 | +61.3% | 22,884 | +3.4% | 0.00% | 0.0% |
| Q1 2017 | $204,000 | -5.1% | 22,121 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $215,000 | -99.9% | 20,661 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $187,471,000 | +21.2% | 20,715 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $154,716,000 | +19.9% | 20,684 | +44.9% | 0.00% | 0.0% |
| Q1 2016 | $129,000,000 | -29.9% | 14,279 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $184,000,000 | +133233.3% | 14,279 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $138,000 | -99.9% | 14,304 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $147,013,000 | +168.6% | 14,287 | +190.0% | 0.00% | – |
| Q1 2015 | $54,728,000 | -4.6% | 4,926 | 0.0% | 0.00% | – |
| Q4 2014 | $57,339,000 | -49.4% | 4,926 | -3.8% | 0.00% | – |
| Q3 2014 | $113,328,000 | -20.4% | 5,121 | -0.1% | 0.00% | -100.0% |
| Q2 2014 | $142,396,000 | – | 5,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |